Lupin receives 6 USFDA observations for Indore plant
Lupin, the pharma major, has received six US FDA Form 483 observations for its Indore plant. The regulator has said that the observations included no...
Tag : Indore plant
Glenmark has received 3 observations from USFDA for Indore plant
Three observations have been received by Glenmark Pharmaceuticals from the US health regulator for its Pithampur, Indore plant. The company, however said that it has...